Literature DB >> 20673595

Hepatitis C virus infection: a "liaison a trois" amongst the virus, the host, and chronic low-level inflammation for human survival.

Vincenzo Barnaba1.   

Abstract

This review covers the various aspects of the immune system that allows the relationship between the hepatitis-C virus, the host and chronic low-level inflammation, to be highly flexible and able to defend the host from persistent infections. This ambiguity mainly stems from the property of the immune system that can be both protective and harmful. Immunity cannot be fully protective without producing a certain degree of damage (acute hepatitis resulting in resolving HCV infection). In addition, the balance between protection and tissue damage is critical for the development of chronic HCV infection. The establishment of a state of chronic low-level inflammation is instrumental to limit liver immunopathology, to limit viral spread, and ultimately to ensure a long-lasting survival of the host. It is dictated by a fine equilibrium maintained by multiple immunologic mechanisms, including: sensory perception of innate immunity, virus-specific T and B cell functions, control of immune responses, and finally the balance between immunity and immunopathology that has principally evolved to favor the survival of the species.
Copyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20673595     DOI: 10.1016/j.jhep.2010.06.003

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  11 in total

1.  Cytomegalovirus duodenitis in immunocompetent patients: what else should we look for?

Authors:  Dalila Costa; Dália Fernandes; Antónia Furtado; Andre Santa Cruz
Journal:  BMJ Case Rep       Date:  2017-06-13

2.  Mouse Hepatitis Virus Infection Induces a Toll-Like Receptor 2-Dependent Activation of Inflammatory Functions in Liver Sinusoidal Endothelial Cells during Acute Hepatitis.

Authors:  Christian Bleau; Aveline Filliol; Michel Samson; Lucie Lamontagne
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

Review 3.  The role of chemokines in acute and chronic hepatitis C infection.

Authors:  Stephen Fahey; Eugene Dempsey; Aideen Long
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

4.  IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin.

Authors:  Norma I Rallón; Vincent Soriano; Susanna Naggie; Clara Restrepo; David Goldstein; Eugenia Vispo; John McHutchison; José M Benito
Journal:  AIDS       Date:  2011-05-15       Impact factor: 4.177

5.  Innate immunity and hepatitis C virus infection: a microarray's view.

Authors:  Luigi Buonaguro; Annacarmen Petrizzo; Maria Lina Tornesello; Franco M Buonaguro
Journal:  Infect Agent Cancer       Date:  2012-03-26       Impact factor: 2.965

6.  Prohibitin is overexpressed in Huh-7-HCV and Huh-7.5-HCV cells harboring in vitro transcribed full-length hepatitis C virus RNA.

Authors:  Shuang-Suo Dang; Ming-Zhu Sun; E Yang; Meng Xun; Li Ma; Zhan-Sheng Jia; Wen-Jun Wang; Xiao-Li Jia
Journal:  Virol J       Date:  2011-09-06       Impact factor: 4.099

7.  Polyfunctional type-1, -2, and -17 CD8⁺ T cell responses to apoptotic self-antigens correlate with the chronic evolution of hepatitis C virus infection.

Authors:  Debora Franceschini; Paola Del Porto; Silvia Piconese; Emanuele Trella; Daniele Accapezzato; Marino Paroli; Stefania Morrone; Enza Piccolella; Enea Spada; Alfonso Mele; John Sidney; Alessandro Sette; Vincenzo Barnaba
Journal:  PLoS Pathog       Date:  2012-06-21       Impact factor: 6.823

8.  Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C.

Authors:  Hassen Kared; Thomas Fabre; Nathalie Bédard; Julie Bruneau; Naglaa H Shoukry
Journal:  PLoS Pathog       Date:  2013-06-20       Impact factor: 6.823

9.  Hepatitis C virus NS3/4A protease inhibits complement activation by cleaving complement component 4.

Authors:  Seiichi Mawatari; Hirofumi Uto; Akio Ido; Kenji Nakashima; Tetsuro Suzuki; Shuji Kanmura; Kotaro Kumagai; Kohei Oda; Kazuaki Tabu; Tsutomu Tamai; Akihiro Moriuchi; Makoto Oketani; Yuko Shimada; Masayuki Sudoh; Ikuo Shoji; Hirohito Tsubouchi
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

Review 10.  Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation.

Authors:  Matti Sällberg; Anna Pasetto
Journal:  Front Immunol       Date:  2020-03-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.